Yes your right should have carried forward $20 million meaning there is an additional $10 million not $30 million that could be called upon. After just listening to Ken Scarince I cannot see that even the extra $10 million will be required.
If anyone has not listened to Ken Scarince yet he confirms that Renesas are building theIr chip incorporating the AKIDA IP presently and should go into production early next year.
In answering questions at the conclusion states that he believes that the present share price undervalues the company.
It is a very open honest presentation.
My opinion only DYOR
FF
AKIDA BALLISTA
- Forums
- ASX - By Stock
- BRN
- RT presentation, 12 Oct 2021
RT presentation, 12 Oct 2021, page-52
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $502.9M |
Open | High | Low | Value | Volume |
26.0¢ | 26.3¢ | 25.0¢ | $3.204M | 12.57M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 434980 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 697239 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 427780 | 0.255 |
40 | 1257219 | 0.250 |
26 | 676596 | 0.245 |
30 | 1130364 | 0.240 |
17 | 828643 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 647239 | 14 |
0.265 | 450991 | 16 |
0.270 | 660781 | 17 |
0.275 | 749952 | 15 |
0.280 | 699752 | 16 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online